Maxcyte (MXCT) Intangibles (2025 - 2026)
Maxcyte's (MXCT) quarterly Intangibles came in at $766000.0 in Q2 2026, up 20.06% year-over-year from $638000.0 in Q2 2025, and down 2.17% quarter-over-quarter from $783000.0 in Q1 2026.
Powered by 
Analysis
Maxcyte (MXCT) Intangibles (2025 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Intangibles for 2 consecutive years, with $766000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Intangibles rose 20.06% year-over-year to $766000.0 in Q2 2026; TTM through Jun 2026 was $766000.0, a 20.06% increase from a year earlier, with the FY2025 full-year figure at $650000.0, changed N/A from the prior year.
- Intangibles was $766000.0 for Q2 2026 at Maxcyte, down from $783000.0 in the prior quarter.
- Over five years, Intangibles peaked at $783000.0 in Q1 2026 and troughed at $638000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 18.61 Bn |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 21.36 Bn |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 906.00 Mn |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 410.00 Mn |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 2.22 Bn |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 895.19 Mn |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 160.00 Mn |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | 580.94 Mn |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | 61.16 Mn |
| 10 | Maxcyte | 131.93 Mn | 131.93 Mn | 5.60 Mn | 766,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 766,000.00 |
| Mar 31, 2026 | 783,000.00 |
| Dec 31, 2025 | 650,000.00 |
| Sep 30, 2025 | 667,000.00 |
| Jun 30, 2025 | 638,000.00 |
| Mar 31, 2025 | 703,000.00 |